Piper Jaffray Said ISIS Pharma (ISIS) To Get Royalty Payments from Alnylam/Roche deal
Tweet Send to a Friend
Piper Jaffray comments on ISIS Pharmaceuticals Inc. (Nasdaq: ISIS), saying the company will get royalty payment from the Alnylam (Nasdaq ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
